As exemplified by Ro 13-3978 (1), aryl hydantoins were identified in the early 1980s as a promising antischistosomal chemotype. We now describe the structure-activity relationship (SAR) of this compound series, which led to the discovery of the drug development candidate AR102 (5). The...